Renaissance Technologies’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Renaissance Technologies’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-26,000	Closed	-$544K	–	3670
2016 Q3	$544K	Buy	+26,000	New	+$299K	﹤0.01%	2785

Renaissance Technologies's VTAE Position: Q4 2016 in Review

Renaissance Technologies sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 26,000 shares — an estimated $544K sold.

Renaissance Technologies first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $544K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Renaissance Technologies reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Renaissance Technologies sold 26,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $544K.
Renaissance Technologies first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Renaissance Technologies's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $544K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.